Has Tamela Swanson received payments from drug or device companies?

Yes. Drug and device makers reported $6,550 in general payments to Tamela Swanson across 257 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tamela Swanson did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tamela Swanson come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tamela Swanson

Psychiatric/Mental Health · Orange Park, FLNPI 1326461773

Payments from drug & device makers

$6,550in general payments, 2019–2025

Across 257 payments — averaging $25.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
AbbVie$1K
Otsuka America Pharmaceutical, Inc.$846
Johnson & Johnson$780
Vanda Pharmaceuticals Inc.$468
Idorsia Pharmaceuticals US Inc$307
plus $1K from 13 others

What the payments were for

Food & beverage$6,50399%
Education$471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	46	$1,486
AbbVie	54	$1,347
Otsuka America Pharmaceutical, Inc.	33	$846
Johnson & Johnson	23	$780
Vanda Pharmaceuticals Inc.	24	$468
Idorsia Pharmaceuticals US Inc	12	$307
Alkermes, Inc.	13	$272
Axsome Therapeutics, Inc.	9	$193
Ironshore Pharmaceuticals Inc.	8	$145
Almatica Pharma LLC	6	$144
Supernus Pharmaceuticals, Inc.	6	$116
Teva Pharmaceuticals USA, Inc.	5	$112
Neurocrine Biosciences, Inc.	4	$87
Corium, LLC	5	$60
Lundbeck LLC	2	$47
Collegium Pharmaceutical, Inc.	2	$45
Noven Therapeutics, LLC	2	$43
Tris Pharma Inc	2	$37
Neos Therapeutics, LP	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,550 in reported general payments places this provider in the 90th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
CaplytaLumateperone Tosylate	17	$32,607
Bupropion XlBupropion Hcl	19	$5,641
Fluoxetine DrFluoxetine Hcl	13	$1,715
Quetiapine Fumarate	37	$1,379
Aripiprazole	14	$732
Hydroxyzine Hcl	22	$628
Lamotrigine ErLamotrigine	12	$621
Olanzapine	16	$538
Escitalopram Oxalate	35	$322
Lamotrigine	53	$297
Alprazolam	12	$278
Venlafaxine Hcl ErVenlafaxine Hcl	11	$272
Buspirone Hcl	34	$231
Clonazepam	30	$225
Trazodone Hcl	25	$201

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta	$1,486	$32,60717 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Orange Park

Nicole HillOrange Park$13K
Roger RiveraKissimmee$1.6M
Bethanie Simmons BecilJacksonville$782K
Hannah PhillipsMaitland$455K
Cheedy JajaTampa$266K
Scott DurrancePensacola$224K
Eudaldo AponteHialeah$214K
Heather WarrenTallahassee$172K
Angela DavenportAlachua$83K
Natalie MoodyWinter Haven$75K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →